PROS1 and allergic asthma: Previous reports from our group had also validated the efficacy of DSV under in vivo experimental design where DSV attenuated pro-inflammatory cytokine response in an induced allergic asthma mouse model (Balkrishna et al., 2020b) and rescued humanized zebrafish (xenotransplanted with human alveolar epithelial A549 cells) from SARS-CoV-2 S-protein-induced pathologies (Balkrishna et al., 2020a).